Navigation Links
Statement From Dr. Dipak Desai
Date:3/10/2008

LAS VEGAS, March 10 /PRNewswire/ -- As a longtime resident of Southern Nevada, I share our community's sorrow and concern for those who have been affected by this situation. I understand that many have questions about the allegations which have been levied against me and the Endoscopy Center of Southern Nevada. While I wish I were allowed to answer those questions, I am unfortunately unable to do so at this time on the advice of legal counsel. These unfounded allegations will be addressed in a court of law, when facts have been presented and substantiated. I look forward to that day, when I will be afforded the right to due process to which we are all entitled as Americans.


'/>"/>
SOURCE Dr. Dipak Desai
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Statement from American Water Works Association on Associated Press Story on Pharmaceuticals in Drinking Water
2. Empire Blue Cross Blue Shield Statement in Response to New York Attorney Generals Recent Subpoenas
3. United Mitochondrial Disease Foundation Statement on Vaccines, Autism and Mitochondrial Disease
4. AHIP Statement on House Passage of Mental Health Parity Legislation
5. Patrick Swayzes Diagnosis With Pancreatic Cancer: a Statement From the Pancreatic Cancer Action Network
6. Roche Statement Regarding Tamiflu U.S. Label Revision
7. Gates Foundation Statement on House Committee Action on Global AIDS, TB, and Malaria
8. Statement of Robert Jarvik, MD, President and CEO of Jarvik Heart, Inc. Regarding the Lipitor DTC Advertisements
9. Statement by Dr. Edward Jones, Chairman of Kidney Care Partners in Response to CMS Payment Bundling Report
10. Statement by Robert D. Foreman, President of The Kidney Care Council, Regarding the HHS Report to Congress A Design for a Bundled End Stage Renal Disease Prospective Payment System
11. Press Statement: Roche Affirms That Tamiflu(R) is in Ample Supply Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... animal healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at ... and joint health in horses at the immunologic level. , The scientifically-developed Flexadin ...
(Date:4/24/2017)... ... 24, 2017 , ... Michael Vick announced his retirement earlier this year from ... overall number one pick in the 2001 NFL Draft, to the Atlanta Falcons, made ... the most career rushing yards by a quarterback (6,109) and the most rushing yards ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner has ... Research Award. The award honors scholars exemplary in their capacity to communicate important ... has demonstrated the capacity to deepen the public’s understanding and appreciation of the ...
(Date:4/24/2017)... ... April 24, 2017 , ... Sean Fay is the ... Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold more than ... marketer in the last 25 years. , Now, due to changes in the broadcast ...
(Date:4/24/2017)... Virginia (PRWEB) , ... April 24, 2017 , ... ... announced that they are seeking public support to bring their novel lifesaving device ... appearance, wearable device packed with medical-grade sensors, specially designed to read a child’s ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... R.I. , April 20, 2017  CVS ... CVS), today unveiled a new store design to ... assortment of healthier food, health-focused products and expanded ... store to help customers discover new offerings. Together ... the next evolution of the customer experience at ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
Breaking Medicine Technology: